Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ovarian Neoplasms

Free Subscription Articles published in Eur J Gynaecol Oncol Retrieve available abstracts of 75 articles: HTML format Text format

Single Articles

January 2016
1. NIEUWENHUYZEN-DE BOER GM, Gerestein CG, Eijkemans MJ, Burger CW, et al
   Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.
   Eur J Gynaecol Oncol. 2016;37:63-8.
   PubMed     Text format     Abstract available
   
   
   
2. MOSZYNSKI R, Szubert S, Tomczak D, Saad A, et al
   Solitary fibrous mass of the omentum mimicking an ovarian tumor: case report.
   Eur J Gynaecol Oncol. 2016;37:144-7.
   PubMed     Text format     Abstract available
   
   
   
3. SOFOUDIS C, Kouiroukidou P, Louis K, Karasaridou K, et al
   Enormous ovarian fibroma with elevated Ca-125 associated with Meigs' syndrome. Presentation of a rare case.
   Eur J Gynaecol Oncol. 2016;37:142-3.
   PubMed     Text format     Abstract available
   
   
   
4. KUNO I, Hashiguchi Y, Kasai M, Fukuda T, et al
   Krukenberg tumor in a 18-year-old-female: a rare case.
   Eur J Gynaecol Oncol. 2016;37:139-41.
   PubMed     Text format     Abstract available
   
   
   
5. LI X, Yang J, Wang X, Li X, et al
   Role of TWIST2, E-cadherin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression.
   Eur J Gynaecol Oncol. 2016;37:100-8.
   PubMed     Text format     Abstract available
   
   
   
6. MA X, Hui Y, Lin L, Wu Y, et al
   Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
   Eur J Gynaecol Oncol. 2016;37:89-94.
   PubMed     Text format     Abstract available
   
   
   
7. KANIS MJ, Kolev V, Getrajdman J, Zakashansky K, et al
   Carcinosarcoma of the ovary: a single institution experience and review of the literature.
   Eur J Gynaecol Oncol. 2016;37:75-9.
   PubMed     Text format     Abstract available
   
   
   
8. SANTOTORIBIO JD, Garcia-de la Torre A, Canavate-Solano C, Arce-Matute F, et al
   Cancer antigens 19.9 and 125 as tumor markers in patients with mucinous ovarian tumors.
   Eur J Gynaecol Oncol. 2016;37:26-9.
   PubMed     Text format     Abstract available
   
   
   
9. TJALMA WA
   Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
   Eur J Gynaecol Oncol. 2016;37:5.
   PubMed     Text format    
   
   
   
10. SHINTANI D, Yoshida H, Imai Y, Fujiwara K, et al
    Acute pancreatitis induced by paclitaxel and carboplatin therapy in an ovarian cancer patient.
    Eur J Gynaecol Oncol. 2016;37:286-7.
    PubMed     Text format     Abstract available
    
    
    
11. JARMUZEK P, Panek G, Gajewska M, Wielgos M, et al
    Ovarian cancer diagnosed accidentally during treatment for ruptured ectopic pregnancy: is fertility-sparing surgery a viable alternative? Case report and review of the literature.
    Eur J Gynaecol Oncol. 2016;37:282-5.
    PubMed     Text format     Abstract available
    
    
    
12. DEXEUS S, Dexeus D, Lugo F
    Possible relation between borderline ovarian cancer and endocervical adenocarcinoma: case report.
    Eur J Gynaecol Oncol. 2016;37:258.
    PubMed     Text format     Abstract available
    
    
    
13. WANG LQ, Zhao WD, Jiao XJ, Du DL, et al
    Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status in ovarian cancer.
    Eur J Gynaecol Oncol. 2016;37:204-10.
    PubMed     Text format     Abstract available
    
    
    
14. WHYNOTT RM, Manahan P, Geisler JP
    Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancer.
    Eur J Gynaecol Oncol. 2016;37:164-6.
    PubMed     Text format     Abstract available
    
    
    
15. KASPRZAK B, Miskiel S, Markowska J
    Nanooncology in ovarian cancer treatment.
    Eur J Gynaecol Oncol. 2016;37:161-3.
    PubMed     Text format     Abstract available
    
    
    
16. KEMAL Y, Kokcu A, Kefeli M, Tosun FC, et al
    Virchow's node metastasis: an unusual presentation of ovarian cancer.
    Eur J Gynaecol Oncol. 2016;37:398-400.
    PubMed     Text format     Abstract available
    
    
    
17. DONG J, Guo H, Chen Y
    Pterostilbene induces apoptosis through caspase activation in ovarian cancer cells.
    Eur J Gynaecol Oncol. 2016;37:342-7.
    PubMed     Text format     Abstract available
    
    
    
18. SZCZESNY W, Vistad I, Kaern J, Nakling J, et al
    Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival.
    Eur J Gynaecol Oncol. 2016;37:305-11.
    PubMed     Text format     Abstract available
    
    
    
19. TSIKOURAS P, Galazios G, Romanidis K, Pinidis P, et al
    Brenner tumour of the ovary--an incidental histological finding.
    Eur J Gynaecol Oncol. 2016;37:267-9.
    PubMed     Text format     Abstract available
    
    
    
20. SULKOWSKI L, Pasternak A, Szura M, Matyja A, et al
    Abrikossoff's tumor mimicking endometrial tumor--literature review and case report of the first described granular cell tumor in scar tissue after caesarean section.
    Eur J Gynaecol Oncol. 2016;37:262-4.
    PubMed     Text format     Abstract available
    
    
    
21. MOLDOVAN B, Pescaru F, Pocreata D, Biris P, et al
    Multimodal oncosurgery approach to treat peritoneal carcinomatosis in a patient with occlusive ovarian carcinoma.
    Eur J Gynaecol Oncol. 2016;37:251-3.
    PubMed     Text format     Abstract available
    
    
    
22. SHO T, Urabe R, Hachisuga T
    Port-site metastasis after laparoscopic surgery for mature cystic teratoma.
    Eur J Gynaecol Oncol. 2016;37:247-50.
    PubMed     Text format     Abstract available
    
    
    
23. KWON YS, Im KS, Choi DI
    Ovarian large cell neuroendocrine carcinoma in the youngest woman.
    Eur J Gynaecol Oncol. 2016;37:244-6.
    PubMed     Text format     Abstract available
    
    
    
24. CIRIK DA, Karalok A, Ureyen I, Tasci T, et al
    Stage IVB endometrial cancer confined to the abdomen: is chemotherapy superior to radiotherapy?
    Eur J Gynaecol Oncol. 2016;37:226-31.
    PubMed     Text format     Abstract available
    
    
    
25. ABUDUKADEER A, Azam S, Zunong B, Mutailipu AZ, et al
    Accuracy of intra-operative frozen section and its role in the diagnostic evaluation of ovarian tumors.
    Eur J Gynaecol Oncol. 2016;37:216-20.
    PubMed     Text format     Abstract available
    
    
    
26. KARADAYI K, Yildiz C, Karakus S, Akkar OB, et al
    Cytoreductive surgery and perioperative intraperitoneal chemotherapy for gynecological malignancies: a single center experience.
    Eur J Gynaecol Oncol. 2016;37:194-8.
    PubMed     Text format     Abstract available
    
    
    
27. GADDUCCI A, Notarnicola M, Menichetti A, Lanfredini N, et al
    Has serum CA 125 assay at the time of relapse a prognostic relevance for patients with recurrent ovarian carcinoma after primary cytoreduction and platinum- and paclitaxel-based chemotherapy?
    Eur J Gynaecol Oncol. 2016;37:182-8.
    PubMed     Text format     Abstract available
    
    
    
28. COSYNS S, Polyzos NP, Carprieaux M, Tournaye H, et al
    The role of appendectomy as part of the treatment of a mucinous borderline ovarian tumor.
    Eur J Gynaecol Oncol. 2016;37:167-70.
    PubMed     Text format     Abstract available
    
    
    
29. SOFOUDIS C, Koumousidis A, Politi E, Koutoulidis V, et al
    Rapidly progressive primary undifferentiated ovarian carcinoma: presentation of a rare case.
    Eur J Gynaecol Oncol. 2016;37:436-8.
    PubMed     Text format     Abstract available
    
    
    
30. SOYAMA H, Takano M, Miyamoto M, Kato M, et al
    Dedifferentiated endometrioid adenocarcinoma of the uterus: a case report.
    Eur J Gynaecol Oncol. 2016;37:426-9.
    PubMed     Text format     Abstract available
    
    
    
31. TOGAMI S, Kawamura T, Kamio M, Douchi T, et al
    A rare case of microinvasive squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Eur J Gynaecol Oncol. 2016;37:420-2.
    PubMed     Text format     Abstract available
    
    
    
32. KURTOGLU E, Celik H, Kokcu A, Kefeli M, et al
    Undifferentiated pleomorphic sarcoma with focally rhabdomyosarcomatous differentiation of the ovary.
    Eur J Gynaecol Oncol. 2016;37:401-3.
    PubMed     Text format     Abstract available
    
    
    
33. LEE DH
    Coexistent mesenteric and ovarian mature cystic teratomas: a case report.
    Eur J Gynaecol Oncol. 2016;37:391-4.
    PubMed     Text format     Abstract available
    
    
    
34. WANG X, He J, Li Y
    Ovarian yolk sac tumor in postmenopausal females: a report of five cases and a literature review.
    Eur J Gynaecol Oncol. 2016;37:374-9.
    PubMed     Text format     Abstract available
    
    
    January 2015
35. ANDROUTSOPOULOS G, Adonakis G, Terzakis E, Geropoulou E, et al
    Endometrial cancer in a patient with rheumatoid arthritis.
    Eur J Gynaecol Oncol. 2015;36:91-3.
    PubMed     Text format     Abstract available
    
    
    
36. LUBIN J, Pawalowska M, Markowska A, Bielas A, et al
    Small cell carcinoma of the ovary of the hypercalcemic type (SCCOHT)--case report.
    Eur J Gynaecol Oncol. 2015;36:88-90.
    PubMed     Text format     Abstract available
    
    
    
37. SHINDE S, Wanger T, Novotny P, Grudem M, et al
    Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive series.
    Eur J Gynaecol Oncol. 2015;36:155-60.
    PubMed     Text format     Abstract available
    
    
    
38. IZYCKA N, Lubin J, Markowska A, Markowska J, et al
    Late recurrence of ovarian cancer: a literature review and description of two cases.
    Eur J Gynaecol Oncol. 2015;36:351-3.
    PubMed     Text format     Abstract available
    
    
    
39. FAN R, Huang W, Luo B, Zhang QM, et al
    Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays.
    Eur J Gynaecol Oncol. 2015;36:298-303.
    PubMed     Text format     Abstract available
    
    
    
40. YE Q, Lei L, Aili AX
    Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis.
    Eur J Gynaecol Oncol. 2015;36:283-9.
    PubMed     Text format     Abstract available
    
    
    
41. GRABOWSKIL JP, Mardas M, Markowska A, Markowska J, et al
    Evaluation of residual tumor locations in advanced ovarian cancer patients after incomplete primary cytoreduction.
    Eur J Gynaecol Oncol. 2015;36:274-7.
    PubMed     Text format     Abstract available
    
    
    
42. SALMENA L, Shaw P, Fans I, McLaughlin, et al
    Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:260-7.
    PubMed     Text format     Abstract available
    
    
    
43. ATES S, Sevket O, Sudolmus S, Sonmez FC, et al
    Granulosa cell tumor presenting with ovarian torsion and de novo borderline mucinous ovarian tumor in the contralateral ovary.
    Eur J Gynaecol Oncol. 2015;36:354-5.
    PubMed     Text format     Abstract available
    
    
    
44. AYDIN A, Ozkanli S, Zemheri E, Girgin B, et al
    Steroid cell tumor of the ovary associated with endometrial adenocarcinoma--a rare case report.
    Eur J Gynaecol Oncol. 2015;36:348-50.
    PubMed     Text format     Abstract available
    
    
    
45. LIU H, Shi Y, Zhang GN, Song SQ, et al
    Addition of bevacizumab to neoadjuvant chemotherapy for Stage IV ovarian serous adenocarcinoma with multiple lymph node metastases: a case report.
    Eur J Gynaecol Oncol. 2015;36:341-5.
    PubMed     Text format     Abstract available
    
    
    
46. MIECZKOWSKA E, Marciniak A, Szydlowska I, Brodowska A, et al
    Rare case of coexistence of primary ovarian carcinoid in mature teratoma with primary serous carcinoma in second ovary--a case report.
    Eur J Gynaecol Oncol. 2015;36:330-2.
    PubMed     Text format     Abstract available
    
    
    
47. AKTURK E, Dede M, Yenen MC, Kocyigit YK, et al
    Comparison of nine morphological scoring systems to detect ovarian malignancy.
    Eur J Gynaecol Oncol. 2015;36:304-8.
    PubMed     Text format     Abstract available
    
    
    
48. ZHUANG XP, Jin WW, Teng XD, Yuan ZZ, et al
    c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.
    Eur J Gynaecol Oncol. 2015;36:255-9.
    PubMed     Text format     Abstract available
    
    
    
49. KOSTRZEWA M, Zyla M, Wladzinski J, Stetkiewicz T, et al
    Metastases of renal clear cell carcinoma to ovary--case report and review of the literature.
    Eur J Gynaecol Oncol. 2015;36:219-22.
    PubMed     Text format     Abstract available
    
    
    
50. WINCEWICZ A, Lewitowicz P, Adamczyk-Gruszka O, Sulkowski S, et al
    Coexistence of mature cystic teratoma and adenocarcinoma in situ within atypical proliferative mucinous tumour of ovary--a case report of 35-year-old woman.
    Eur J Gynaecol Oncol. 2015;36:206-9.
    PubMed     Text format     Abstract available
    
    
    
51. ICHIGO S, Takagi H, Matsunami K, Murase T, et al
    A large ovarian leiomyoma discovered incidentally in a 76-year-old woman: case report.
    Eur J Gynaecol Oncol. 2015;36:203-5.
    PubMed     Text format     Abstract available
    
    
    
52. GENC M, Solak A, Genc B, Sivrikoz ON, et al
    A diagnostic dilemma for solid ovarian masses: the clinical and radiological aspects with differential diagnosis of 23 cases.
    Eur J Gynaecol Oncol. 2015;36:186-91.
    PubMed     Text format     Abstract available
    
    
    
53. LILI X, Xiaoyu T
    Expression of PKCalpha, PKCepsilon, and P-gp in epithelial ovarian carcinoma and the clinical significance.
    Eur J Gynaecol Oncol. 2015;36:181-5.
    PubMed     Text format     Abstract available
    
    
    
54. UMEZAKI Y, Ito M, Nakashima M, Mihara Y, et al
    S100P is a useful marker for differentiation of ovarian mucinous tumors.
    Eur J Gynaecol Oncol. 2015;36:138-41.
    PubMed     Text format     Abstract available
    
    
    
55. LING S, Ruiqin M, Guohong Z, Ying W, et al
    Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:463-8.
    PubMed     Text format     Abstract available
    
    
    
56. DIKMEN ZG, Colak A, Dogan P, Tuncer S, et al
    Diagnostic performances of CA125, HE4, and ROMA index in ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:457-62.
    PubMed     Text format     Abstract available
    
    
    
57. YOSHIHAMA T, Chiyoda T, Kataoka F, Nomura H, et al
    Effectiveness of third-line chemotherapy in recurrent ovarian cancer patients.
    Eur J Gynaecol Oncol. 2015;36:424-7.
    PubMed     Text format     Abstract available
    
    
    
58. ZHU Y, Tian Q, Qiao N, Cheng Y, et al
    Anti-Hsp20 antibody concentrations inversely correlated with tumor progression in ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:394-6.
    PubMed     Text format     Abstract available
    
    
    
59. SHIMOKAWA M, Ohki M, Kaku T
    Correlation of progression-free and post-progression survival with overall survival in phase III trials of first-line chemotherapy for advanced epithelial ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:370-5.
    PubMed     Text format     Abstract available
    
    
    
60. SOUFI M, Lupinacci RM, Godiris-Petit G, Vignot S, et al
    Growing teratoma syndrome of the ovary presenting with liver metastasis: report of a case.
    Eur J Gynaecol Oncol. 2015;36:473-6.
    PubMed     Text format     Abstract available
    
    
    
61. GEELS YP, van der Putten LJ, van der Steen-Banasik EM, Snijders MP, et al
    The opinion of gynecologists on the management of early-stage, high-grade endometrioid endometrial cancer.
    Eur J Gynaecol Oncol. 2015;36:402-5.
    PubMed     Text format     Abstract available
    
    
    
62. PRAT J, Belhadj H, Berek J, Bermudez A, et al
    Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Eur J Gynaecol Oncol. 2015;36:367-9.
    PubMed     Text format    
    
    
    
63. HOU Q, Chen K, Shan Z
    The construction of cDNA library and the screening of related antigen of ascitic tumor cells of ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:590-4.
    PubMed     Text format     Abstract available
    
    
    
64. YE X
    Confluence analysis of multiple omics on platinum resistance of ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:514-9.
    PubMed     Text format     Abstract available
    
    
    
65. GURASLAN H, Yasar L, Ekin M, Kaya C, et al
    A successful management of a giant mucinous ovarian tumor with intraoperative controlled fluid aspiration.
    Eur J Gynaecol Oncol. 2015;36:615-7.
    PubMed     Text format     Abstract available
    
    
    
66. SHA-SHA H, Li H, Jie M, Gui F, et al
    DVP parametric imaging for characterizing ovarian masses in contrast-enhanced ultrasound.
    Eur J Gynaecol Oncol. 2015;36:574-8.
    PubMed     Text format     Abstract available
    
    
    
67. TERZI H, Kale E, Kale A, Turkay U, et al
    New method: Are tumor markers in vaginal-washing fluid significant in the diagnosis of primary ovarian carcinoma?
    Eur J Gynaecol Oncol. 2015;36:560-3.
    PubMed     Text format     Abstract available
    
    
    
68. GUO Q, Yang X, Ma Y, Ma L, et al
    Syndecan-1 serves as a marker for the progression of epithelial ovarian carcinoma.
    Eur J Gynaecol Oncol. 2015;36:506-13.
    PubMed     Text format     Abstract available
    
    
    
69. LAGANA AS, Colonese F, Colonese E, Sofo V, et al
    Cytogenetic analysis of epithelial ovarian cancer's stem cells: an overview on new diagnostic and therapeutic perspectives.
    Eur J Gynaecol Oncol. 2015;36:495-505.
    PubMed     Text format     Abstract available
    
    
    
70. SEGEV Y, Zhang S, Akbari MR, Sun P, et al
    Survival in women with ovarian cancer with and without microsatellite instability.
    Eur J Gynaecol Oncol. 2015;36:681-4.
    PubMed     Text format     Abstract available
    
    
    
71. XIA X, Ji T, Liu R, Weng Y, et al
    Cytoplasmic p21 is responsible for paclitaxel resistance in ovarian cancer A2780 cells.
    Eur J Gynaecol Oncol. 2015;36:662-6.
    PubMed     Text format     Abstract available
    
    
    
72. SEGEV Y, Ismiil N, McVey R, Covens A, et al
    Surgical Stage I high-grade ovarian cancer: is adjuvant chemotherapy warranted?
    Eur J Gynaecol Oncol. 2015;36:633-6.
    PubMed     Text format     Abstract available
    
    
    
73. ZHANG G, Liu Z, Qin S, Li K, et al
    Decreased expression of SIRT6 promotes tumor cell growth correlates closely with poor prognosis of ovarian cancer.
    Eur J Gynaecol Oncol. 2015;36:629-32.
    PubMed     Text format     Abstract available
    
    
    
74. GRAUSO F, Messalli EM, Salzillo ME, Di Martino L, et al
    Ovarian fibrosarcoma: case report and latest trends in diagnostic and therapeutic management.
    Eur J Gynaecol Oncol. 2015;36:742-5.
    PubMed     Text format     Abstract available
    
    
    
75. BLEU G, Arsene E, Merlot B, Kerdraon O, et al
    How to improve the preoperative staging of presumed early-stage endometrioid endometrial cancer?
    Eur J Gynaecol Oncol. 2015;36:698-702.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: